BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2912736)

  • 21. [In vitro and in vivo studies of murine erythropoietic recovery after treatment with cyclophosphamide].
    Aguirre MV; Juaristi JA; Alba Alvarez M; Carmuega RJ; Brandan NC
    Sangre (Barc); 1999 Jun; 44(3):182-7. PubMed ID: 10481578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevation of erythroid colony-stimulating activity in the serum of mice with graft-versus-host disease.
    Kanamaru A; Okamoto T; Matsuda K; Hara H; Nagai K
    Exp Hematol; 1984 Nov; 12(10):763-7. PubMed ID: 6334610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythropoiesis in the aged mouse: II. Response to stimulation in vitro.
    Udupa KB; Lipschitz DA
    J Lab Clin Med; 1984 Apr; 103(4):581-8. PubMed ID: 6699473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
    Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulatory effects of plasma from patients with acute nonlymphoblastic leukemia on early erythroid progenitors and pluripotent stem cells.
    Kobari L; Dainiak N; Najman A; Kreczko S; Gorin NC; Duhamel G; Frindel E
    Exp Hematol; 1987 Sep; 15(8):838-44. PubMed ID: 3622657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. v-src interferes with the in vitro erythropoietic stimulatory ability of spleen stromal cells through repression of vascular cell adhesion molecule-1 and stem cell factor.
    Yanai N; Shimizu A; Koguma M; Obinata M
    Exp Hematol; 1996 Jul; 24(8):883-7. PubMed ID: 8690046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin assays: some new and different approaches.
    Lange RD; Chen JP; Dunn CD
    Exp Hematol; 1980; 8 Suppl 8():197-224. PubMed ID: 6897637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of red cell membrane proteins in erythroid precursor cells.
    Yurchenco PD; Furthmayr H
    J Supramol Struct; 1980; 13(2):255-69. PubMed ID: 6941050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of natural killer cell activity in infant mice occurs after target cell binding.
    Dussault I; Miller SC
    Nat Immun; 1995; 14(1):35-43. PubMed ID: 7599460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin.
    Muta K; Krantz SB
    J Cell Physiol; 1993 Aug; 156(2):264-71. PubMed ID: 7688370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protease induction of hemoglobin synthesis but not terminal cell division in K562 cells.
    Scher W; Hellinger N; Waxman S
    Exp Hematol; 1985 Jan; 13(1):36-43. PubMed ID: 3882441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of conditioned medium from bone marrow of normal and Ara-C-treated mice on hemoglobin synthesis.
    Boffa GA; Dumenil D; Lucien N; Winchenne JJ; Frindel E
    Exp Hematol; 1982 Sep; 10(8):675-81. PubMed ID: 7140868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
    Perl A; Looney RJ; Ryan DH; Abraham GN
    J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietin control of terminal erythroid differentiation: maintenance of cell viability, production of hemoglobin, and development of the erythrocyte membrane.
    Koury MJ; Bondurant MC; Atkinson JB
    Blood Cells; 1987; 13(1-2):217-26. PubMed ID: 3478108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The erythrotropins, new factors which stimulate thymidine incorporation and globin chain synthesis in liver erythroid cells.
    Congote LF
    Prog Clin Biol Res; 1984; 165():29-45. PubMed ID: 6504913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of normal human serum erythropoietin levels, using mouse bone marrow.
    Krystal G; Eaves AC; Eaves CJ
    J Lab Clin Med; 1981 Feb; 97(2):158-69. PubMed ID: 7452087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in the proliferative activity of L cells in response to immune sera].
    Simonova AV; Khorobrykh VV; Lebedev KA
    Biull Eksp Biol Med; 1981 Sep; 92(9):337-9. PubMed ID: 7295990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro studies of erythropoietic progenitors (CFU-E) in marrow from neonatal and young mice.
    Hall EA; Shinpock SG; Goodman JW
    Exp Hematol; 1984 Aug; 12(7):549-57. PubMed ID: 6745330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of transferrin saturation on the estimation of erythropoietin by the mouse spleen cell microassay.
    Lappin TR; Elder GE; McKibbin SH; McNamee PT; McGeown MG; Bridges JM
    Exp Hematol; 1985 Nov; 13(10):1007-13. PubMed ID: 4054239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.